Prostate Cancer Program Research Workshop: Perioperative Therapies in High Risk Localized Prostate Cancer

Perioperative Therapies in High Risk Localized Prostate Cancer

State of the Art: High Risk Localized and Oligometastatic Prostate Cancer (Moderator, Eric Small, MD)

• Ivan de Kouchkovsky, MD
  Neoadjuvant Approaches to High Risk Localized Prostate Cancer: What We Can Learn from PROTEUS
• Steven Seyedin, MD
  Radiation Therapy Approaches to High Risk Localized Prostate Cancer: What We Can Learn from STAMPEDE and ENZARAD
• Cornelia Ding, MD, PhD
  Defining High Risk Localized Prostate Cancer Pathologically: New and Emerging Biomarkers of Risk
• Carissa Chu, MD
  The UCSF Neoadjuvant Study Pipeline: Lessons Learned from Prior and Current Studies, and Next Gen Trials in Development

Correlatives, Opportunities and Prospects (Moderator, Carissa Chu, MD)

• Matthew Cooperberg, MD, MPH
  Identifying High Risk Localized Prostate Cancer Using Contemporary and Next Gen Risk Stratification Tools
• David Oh, MD, PhD
  Neoadjuvant Immunotherapy Trials in Prostate Cancer: Lessons Learned and Future Opportunities
• Will Chen, MD
  Embedding Spatial Proteomics in Neoadjuvant Approaches

Next Steps: Panel Discussion and Q&A (Moderator, Peter Carroll, MD, MPH)

• Rahul Aggarwal, MD
• Will Chen, MD
• Carissa Chu, MD
• Matthew Cooperberg, MD, MPH
• Ivan de Kouchkovsky, MD
• Cornelia Ding, MD, PhD
• David Oh, MD, PhD
• Steven Seyedin, MD
• Eric Small, MD

This workshop is open to the UCSF cancer research community. For details, please RSVP.

This is not a public event.